title: Does biological therapy affect interferon-γ release assay response? A long-term follow-up of patients with psoriasis using QuantiFERON-TB.
authors.affiliation: Microbiology Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Lombardi
authors.forename: V
authors.initials: V
authors.lastname: Tengattini
authors.forename: P
authors.initials: P
authors.lastname: Dal Monte
authors.forename: A
authors.initials: A
authors.lastname: Denicolò
authors.forename: M L
authors.initials: ML
authors.lastname: Bacchi Reggiani
authors.forename: A
authors.initials: A
authors.lastname: Patrizi
authors.forename: M P
authors.initials: MP
authors.lastname: Landini
authors.forename: F
authors.initials: F
authors.lastname: Bardazzi
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001691:Biological Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D059425:Interferon-gamma Release Tests; D055985:Latent Tuberculosis / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D012189:Retrospective Studies; D055815:Young Adult